Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

NCT03057990 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study never opened; closed on 06/29/2021 due to no enrllment

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Pyrimethamine

Sponsor

Montefiore Medical Center

Collaborators

[object Object]